dr. d ross camidge on teliso-v monotherapy in patients with previously treated c-met advanced nsclc
Published 3 years ago • 655 plays • Length 9:36Download video MP4
Download video MP3
Similar videos
-
2:29
dr. ross camidge discusses crizotinib in ros1 rearranged nsclc
-
1:55
dr. d. ross camidge on targeted therapies in adjuvant non-small cell lung cancer
-
1:28
dr. camidge on ap26113 in patients with advanced malignancies
-
6:19
ross camidge: brigatinib for adult patients with alk metastatic non-small cell lung cancer
-
8:33
understanding the alta-1l trial and second interim analysis results: d. ross camidge,
-
1:52
d. ross camidge discusses brain metastases in patients with lung cancer
-
6:20
understanding hazard ratio: d. ross camidge, m.d., ph.d., joyce zeff chair in lung cancer research
-
1:00
dr. camidge on phase i study with azd9291 in nsclc
-
40:28
alk summit 2024: dr. ross camidge - right in front of us
-
1:08:55
ask the expert: dr. ross camidge
-
3:26
new pill offers hope for some people with lung cancer l gma
-
1:45
chemotherapy approaches in locally advanced nsclc
-
56:39
the ros1ders interview dr ross camidge 16 may 2019
-
3:21
phase 1 study of crizotinib in patients with alk-positive non-small cell lung cancer
-
1:25
biopsying tumor - dr ross camidge
-
1:52
dr. camidge on optimal therapy in egfr nsclc
-
1:51
dr. camidge discusses treatment of patients with alk nsclc
-
1:09
dr. camidge on crizotinib as a ros1 inhibitor in nsclc
-
1:19
dr. ross camidge discusses resequencing lung cancer
-
1:40
revolutionary cancer treatment - dr ross camidge
-
2:29:54
striving for consensus on the management of alk-positive lung cancer
-
1:27
dr. camidge on the keynote-024 trial in nsclc